Nongenital herpes simplex virus

American Family Physician

Volumn 82, Issue 9, 2010, Pages 1075-1082

  Usatine, Richard P ^a   Tinitigan, Rochelle ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANALGESIC AGENT; ANESTHETIC AGENT; BEHENYL ALCOHOL; CLOBETASOL; CLOBETASOL PROPIONATE; FAMCICLOVIR; PENCICLOVIR; PLACEBO; VALACICLOVIR; VIRUS DNA; ANTIVIRUS AGENT;

ANTIVIRAL ACTIVITY; APHTHOUS ULCER; ARTICLE; BEHCET DISEASE; COLD TREATMENT; CREAM; DIFFERENTIAL DIAGNOSIS; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEVER; FLUORESCENT ANTIBODY TECHNIQUE; HERPANGINA; HERPES LABIALIS; HERPES SIMPLEX VIRUS 1; HERPES ZOSTER; HERPETIC STOMATITIS; HUMAN; HYDRATION; NONGENITAL HERPES SIMPLEX; NONHUMAN; PARESTHESIA; PARONYCHIA; PATHOPHYSIOLOGY; PEMPHIGOID GESTATIONIS; PEMPHIGUS VULGARIS; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; SEROPREVALENCE; SINGLE DRUG DOSE; SYMPTOMATOLOGY; SYSTEMATIC REVIEW (TOPIC); TREATMENT DURATION; TZANCK TEST; VIRUS CULTURE; VIRUS LOAD; VIRUS TRANSMISSION; EPIDEMIOLOGY; HERPES SIMPLEX; ORAL DRUG ADMINISTRATION; UNITED STATES;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 79952115916     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964-973.
2. Gibson JJ, Hornung CA, Alexander GR, Lee FK, Potts WA, Nahmias AJ. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis. 1990;162(2):306-312.
3. Gilbert S, Corey L, Cunningham A, et al. An update on short-course intermittent and prevention therapies for herpes labialis. Herpes. 2007;14(suppl 1):13A-18A.
4. Boivin G, Goyette N, Sergerie Y, Keays S, Booth T. Longitudinal evaluation of herpes simplex virus DNA load during episodes of herpes labialis. J Clin Virol. 2006;37(4):248-251.
5. Cernik C, Gallina K, Brodell RT. The treatment of herpes simplex infections: an evidence-based review. Arch Intern Med. 2008;168(11):1137-1144.
6. Lafferty WE, Coombs RW, Benedetti J, Critchlow C, Corey L. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type. N Engl J Med. 1987;316(23):1444-1449.
7. Chumley H. Conjunctivitis. In: Usatine RP, Smith MA, Chumley H, Mayeaux EJ Jr, Tysinger J, eds. The Color Atlas of Family Medicine. New York, NY: McGraw-Hill; 2009:83.
8. Mayeaux EJ Jr. Herpes simplex. In: Usatine RP, Smith MA, Chumley H, Mayeaux EJ Jr, Tysinger J, eds. The Color Atlas of Family Medicine. New York, NY: McGraw-Hill; 2009:517.
9. Spruance SL, Overall JC Jr, Kern ER, Krueger GG, Pliam V, Miller W. The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med. 1977;297(2):69-75.
10. Chan EL, Brandt K, Horsman GB. Comparison of Chemicon SimulFluor direct fluorescent antibody staining with cell culture and shell vial direct immunoperoxidase staining for detection of herpes simplex virus and with cytospin direct immunofluorescence staining for detection of varicella-zoster virus. Clin Diagn Lab Immunol. 2001;8(5):909-912.
11. Chauvin PJ, Ajar AH. Acute herpetic gingivostomatitis in adults: a review of 13 cases, including diagnosis and management. J Can Dent Assoc. 2002;68(4):247-251.
12. Amir J, Harel L, Smetana Z, Varsano I. Treatment of herpes simplex gingivostomatitis with aciclovir in children: a randomised double blind placebo controlled study. BMJ. 1997;314(7097):1800-1803.
13. Glenny AM, Fernandez Mauleffinch LM, Pavitt S, Walsh T. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer. Cochrane Database Syst Rev. 2009;(1):CD006706.
14. Spruance SL, Bodsworth N, Resnick H, et al. Single-dose, patient-initiated famciclovir: a randomized, double-blind, placebo-controlled trial for episodic treatment of herpes labialis. J Am Acad Dermatol. 2006;55(1):47-53.
15. Hull C, McKeough M, Sebastian K, Kriesel J, Spruance S. Valacyclovir and topical clobetasol gel for the episodic treatment of herpes labialis: a patient-initiated, double-blind, placebo-controlled pilot trial. J Eur Acad Dermatol Venereol. 2009;23(3):263-267.
16. Spruance SL, Rea TL, Thoming C, Tucker R, Saltzman R, Boon R. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group. JAMA. 1997;277(17):1374-1379.
17. Sacks SL, Thisted RA, Jones TM, et al.; Docosanol 10% Cream Study Group. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J Am Acad Dermatol. 2001;45(2):222-230.
18. Spruance SL, Nett R, Marbury T, Wolff R, Johnson J, Spaulding T. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials. Antimicrob Agents Chemother. 2002;46(7):2238-2243.
19. Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial. Ann Intern Med. 1993;118(4):268-272.
20. Baker D, Eisen D. Valacyclovir for prevention of recurrent herpes labialis: 2 double-blind, placebo-controlled studies. Cutis. 2003;71(3):239-242.
21. Miserocchi E, Modorati G, Galli L, Rama P. Efficacy of valacyclovir vs acyclovir for the prevention of recurrent herpes simplex virus eye disease: a pilot study. Am J Ophthalmol. 2007;144(4):547-551.